543 results
Embrace the innovation in PCI and TAVR: Robocath R-One vascular robot for PCI in China, MicroPort Firehawk TES stent, and VitaFlow valve
18 May 2022 – From EuroPCR 2022
The objective of this EuroPCR 2022 session is to highlight MicroPort's innovation portfolio in 3 different fields: learn more about the clinical performance of Firehawk Family stent in STEMI patients evaluated by imaging tools, the features and benefits of PCI robot R-ONE and first clinical trial updates in China,...
Pressure microcatheter guided PCI: to optimise stent implantation and to safely assess the functional result
18 May 2022 – From EuroPCR 2022
Through the case study of a 71-year-old female patient with hypertension, dyslipidemia, previous TIA, and stress-induced chest pain, among other things, this EuroPCR 2022 session will allow you to understand the major role of longitudinal functional evaluation of CAD, learn tips and tricks in using pressure microcatheter in PCI...
The current role of paclitaxel DCB in PCI
18 May 2022 – From EuroPCR 2022
Thanks to the different interventions of this EuroPCR 2022 session, understand the role of paclitaxel DCB in modern era interventional cardiology, the differences, and advantages versus DES, the role of blended therapies in CLS, and learn how to correctly prepare the lesion and obtain the best from this technology on...
Stents in challenging situations
18 May 2022 – From EuroPCR 2022
Watch this session to discover the use and outcome of a selection of abstract submissions concerning: the treatment of diffuse CAD with one long stent vs. multistents, novel uncaging bioadaptor for coronary revascularisation, one-month DAPT in high bleeding risk ACS patients and much more.
Complex PCI after bypass grafts failure
17 May 2022 – From EuroPCR 2022
Discover the case of a 76 year-old female patient presenting with unstable angina, history of CABG and SVG and various risk factors (dyslipidemia, hypertension and type 2 diabetes). Angiography revealed a severe calcification of left main and left anterior descending artery with a tight stenosis, a...
Fractured stent and aneurysmal expansion of the coronary artery
17 May 2022 – From EuroPCR 2022
Discover the case of a 51 year-old male presenting with stable angina, with an history of ischemic heart disease (stented several times), hypertension and benign lung tumor (active smoker). Angiogram revealed a mid LCx CTO, a mid LAD aneurysmal extended with distal part occluded and an...
The freaky and rocky road
17 May 2022 – From EuroPCR 2022
Discover the case of a 85 year-old female patient presenting with angina during dialysis and LVEF 55% with hypokinesia in inferior wall. Angiogram reveals an anomalous RCA from left sinus with a mid-RCA calcified CTO. Watch the video to learn more about the treatment's option!
EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary physiology: DECISION QFR, INOCA, and PROPHET-FFR
17 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in coronary physiology! Angiography-derived coronary microcirculatory assessment in INOCA patients, Heart Team decision-making based on angiography-derived FFR: DECISION QFR, and safety and efficacy of post-PCI physiological assessment: PROPHET-FFR.
EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary artery disease: MASTER DAPT, CRUZ-HBR, DISCO RADIAL, and more!
17 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in coronary artery disease! Abbreviated DAPT after complex PCI in high bleeding risk patients, comparing conventional and haemostatic dressings in radial access, angio-based QFR virtual PCI vs. conventional angio-guided PCI, CRUZ-HBR, CT-guided invasive coronary angiography in patients with...
Sirolimus coated balloon and coronary artery disease: expanding the treatment indications
17 May 2022 – From EuroPCR 2022
Through a case presentation, as well as upcoming studies and rationale for the Food and Drug Administration, the aim of this EuroPCR 2022 session is to help you answer the following questions: how can the use of a sirolimus-coated DCB be expanded in new and challenging treatment indications? Why is...
